AR, androgen receptor, 367

N. diseases: 854; N. variants: 163
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Prostatic Neoplasms, Castration-Resistant
0.300 Biomarker disease CTD_human Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway. 28757136 2017
Prostatic Neoplasms, Castration-Resistant
0.300 Biomarker disease CTD_human Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer. 28500234 2017
Prostatic Neoplasms, Castration-Resistant
0.300 Biomarker disease CTD_human Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer. 24740322 2014
Prostatic Neoplasms, Castration-Resistant
0.300 Biomarker disease CTD_human CYP17 inhibition as a hormonal strategy for prostate cancer. 18985049 2008